Munafa Stock Market Course + Intraday & FNO calls 
Galectin Therapeutics (GALT) Technical (Analysis) Reports Galectin Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Galectin Therapeutics (GALT)
Technical Analysis Report for USA stock GALT Galectin Therapeutics. Dated: 04 May 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock GALT Galectin Therapeutics then click here. or read Experts views on Galectin Therapeutics or Forecast & share price targets of Galectin Therapeutics
Galectin Therapeutics Opened at 2.26 and Closed at: 2.29, which is 0.87% of previous session's close. It moved within a range of 2.24 and 2.35
The session was a Bullish session with an average volume of 282800, which is 36.88% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 2.27 and resistance for tomorrow is 2.38
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 2.24, 2.18 resistance for tomorrow's hourly charts is 2.35, 2.4
10 Day SMA for Galectin Therapeutics (GALT) is 2.32 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Galectin Therapeutics (GALT) is 2.34 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Galectin Therapeutics (GALT) is 2.71 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 3.25 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Galectin Therapeutics is 3.94 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Galectin Therapeutics is at 2.34 and 200 DMA is at 3.94, while 50 DMA and 100 DMA are at 2.71 and 3.25 respectively
Galectin Therapeutics (GALT) moving average of 20 SMA is at 2.34 and 20 EMA is at 2.39
| Date | Closing Price | 20 SMA | 20 EMA |
| 04 Mon May | 2.29 | 2.34 | 2.39 |
| 01 Fri May | 2.27 | 2.35 | 2.4 |
| 30 Thu Apr | 2.27 | 2.37 | 2.41 |
| 29 Wed Apr | 2.25 | 2.39 | 2.43 |
| 28 Tue Apr | 2.32 | 2.42 | 2.45 |
| 27 Mon Apr | 2.37 | 2.43 | 2.46 |
Galectin Therapeutics (GALT) moving average of 50 SMA is at 2.71 and 50 EMA is at 2.66
| Date | Closing Price | 50 SMA | 50 EMA |
| 04 Mon May | 2.29 | 2.71 | 2.66 |
| 01 Fri May | 2.27 | 2.72 | 2.68 |
| 30 Thu Apr | 2.27 | 2.73 | 2.7 |
| 29 Wed Apr | 2.25 | 2.74 | 2.72 |
| 28 Tue Apr | 2.32 | 2.75 | 2.74 |
| 27 Mon Apr | 2.37 | 2.76 | 2.76 |
Galectin Therapeutics (GALT) moving average of 100 SMA is at 3.25 and 100 EMA is at 3.06
| Date | Closing Price | 100 SMA | 100 EMA |
| 04 Mon May | 2.29 | 3.25 | 3.06 |
| 01 Fri May | 2.27 | 3.28 | 3.08 |
| 30 Thu Apr | 2.27 | 3.32 | 3.1 |
| 29 Wed Apr | 2.25 | 3.36 | 3.12 |
| 28 Tue Apr | 2.32 | 3.39 | 3.14 |
| 27 Mon Apr | 2.37 | 3.42 | 3.16 |
Galectin Therapeutics (GALT) moving average of 200 SMA is at 3.94 and 200 EMA is at 3.27
| Date | Closing Price | 200 SMA | 200 EMA |
| 04 Mon May | 2.29 | 3.94 | 3.27 |
| 01 Fri May | 2.27 | 3.95 | 3.28 |
| 30 Thu Apr | 2.27 | 3.95 | 3.29 |
| 29 Wed Apr | 2.25 | 3.95 | 3.3 |
| 28 Tue Apr | 2.32 | 3.95 | 3.31 |
| 27 Mon Apr | 2.37 | 3.95 | 3.32 |
Galectin Therapeutics has performed better than Penumbra Inc in short term. Holding Galectin Therapeutics could be a better choice for now!
Xeris Pharmaceuticals has performed better than Galectin Therapeutics in short term. You could have earned much better returns by investing in Xeris Pharmaceuticals, about 2.77% more returns!
Galectin Therapeutics has performed better than Phio Pharmaceuticals in short term. Holding Galectin Therapeutics could be a better choice for now!
Outlook Therapeutics has performed better than Galectin Therapeutics in short term. You could have earned much better returns by investing in Outlook Therapeutics, about 18.76% more returns!
Galectin Therapeutics has performed better than Natera Inc in short term. Holding Galectin Therapeutics could be a better choice for now!
Iovance Biotherapeutics has performed better than Galectin Therapeutics in short term. You could have earned much better returns by investing in Iovance Biotherapeutics, about 10.91% more returns!
Immucell Corporation has performed better than Galectin Therapeutics in short term. You could have earned much better returns by investing in Immucell Corporation, about 27.07% more returns!
Galectin Therapeutics has performed better than Galmed Pharmaceuticals in short term. Holding Galectin Therapeutics could be a better choice for now!
Galectin Therapeutics has performed better than Fonar Corporation in short term. Holding Galectin Therapeutics could be a better choice for now!
Galectin Therapeutics has performed better than Eyegate Pharmaceuticals in short term. Holding Galectin Therapeutics could be a better choice for now!
Evolus Inc has performed better than Galectin Therapeutics in short term. You could have earned much better returns by investing in Evolus Inc, about 31.96% more returns!
Dare Bioscience has performed better than Galectin Therapeutics in short term. You could have earned much better returns by investing in Dare Bioscience, about 70.66% more returns!
Bioxcel Therapeutics has performed better than Galectin Therapeutics in short term. You could have earned much better returns by investing in Bioxcel Therapeutics, about 10.55% more returns!
Autolus Therapeutics has performed better than Galectin Therapeutics in short term. You could have earned much better returns by investing in Autolus Therapeutics, about 10.28% more returns!
Array Biopharma has performed better than Galectin Therapeutics in short term. You could have earned much better returns by investing in Array Biopharma, about 7.1% more returns!
Aptevo Therapeutics has performed better than Galectin Therapeutics in short term. You could have earned much better returns by investing in Aptevo Therapeutics, about 25.65% more returns!
Galectin Therapeutics has performed better than Allogene Therapeutics in short term. Holding Galectin Therapeutics could be a better choice for now!
Galectin Therapeutics Technical analysis of indicators
Price action analysis of Galectin Therapeutics (GALT) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Galectin Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Galectin Therapeutics in short term but the buy signal is initial and weak.
Galectin Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Galectin Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Galectin Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.32 and Galectin Therapeutics GALT stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Galectin Therapeutics GALT stock. Volume based technical analysis of Galectin Therapeutics GALT stock is negative.
Galectin Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock GALT Galectin Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And GALT Experts View which covers a lot of information including buying and selling signals
GALT future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Galectin Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Galectin Therapeutics (GALT) Technical (Analysis) Reports Galectin Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
